* migrena
Two studies suggest that migraine with aura increases risk for CVD and CHD mortality.
Dizziness, and vertigo are common in the general population and are often a patient complaint. These symptoms occur more commonly with, and may be
part of the migraine attack. Look for migraine in your patients complaining of dizziness or vertigo. Treating migraine may relieve these symptoms.
*dementa
- In the past few years, a small number of controlled studies have explored the effectiveness of some of the more popular herbal and CAM remedies, including gingko biloba, phosphatidylcholine, phosphatidylserine, and omega–3 fatty acids.
- To date, the bulk of evidence suggests that such approaches are not successful in preventing or delaying cognitive decline or dementia, and there is little reason to prescribe these remedies for the treatment of established cognitive impairment.
*clozapina si reinternarile
Werneck AP et al. – Clozapine was significantly associated with lower rehospitalization risk compared with risperidone. The risk of rehospitalization in patients on
olanzapine and amisulpride, and oral first generation antipsychotics (FGA), was similar to that of patients in use of clozapine. These results however, are limited by the heterogeneity of
illness severity across the groups
*antidepresivele la batrini
August 5, 2011 — Use of antidepressant medication in those over age 65 is risky, new research suggests.
A population-based cohort study in the United Kingdom published
online August 2 in the British Medical Journal showed significant associations between the use of antidepressants and adverse outcomes,
including falls, stroke, seizures, and all-cause mortality in elderly people with depression.
No comments:
Post a Comment